Relapsed or Refractory B-cell Lymphoma
10 clinical trials · Condition
◉ Watch Relapsed or Refractory B-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Exploratory Study of a Novel Oncolytic Vaccinia Virus RGV004 in the Treatment of Refractory/Relapsed B-cell Lymphoma (NCT04887025) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2022-02-08 |
| Study of A-319 in Patients With Relapsed or Refractory B-cell Lymphoma (NCT04056975) | EVIVE Biotechnology | 2019-09-15 |
| Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma (NCT03208556) | Peking University | 2017-06-21 |
| CART-19 Cells for R/R B-cell Lymphoma (NCT03391726) | Fujian Medical University | 2016-01-01 |
Track Relapsed or Refractory B-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.